跳至主要内容
临床试验/NCT04641325
NCT04641325已完成不适用

Evaluating the Effects of Moderate Physical Activity on Health and Well-being in Adolescents and Young Adults With Marfan Syndrome

Baylor College of Medicine2 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2020年11月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
23
试验地点
2
主要终点
Maximum VO2

研究概览

简要总结

Marfan syndrome (MFS) affects multiple organ systems including the heart, bones, ligaments, and eyes, and is associated with significant risk of aortic dissection. Given limited evidence from in-vitro studies, and theoretical concerns, the majority of patients with MFS are restricted from certain physical activities. The lack of exercise and deconditioning have detrimental effects including increasing weakness, joint pain, decreased endurance, and depressive symptoms. Given the significant paucity of data currently existing on the effects of exercise in humans with MFS, and the recent, optimistic findings in rodent models, this pilot trial was established to assess the effects of moderated dynamic exercise in adolescents and young adults with MFS.

详细描述

Marfan syndrome (MFS) affects multiple organ systems including the heart, bones, ligaments, and eyes, and is associated with significant risk of aortic dissection. Given anecdotal reports of aortic dissection, limited evidence from in-vitro studies, and theoretical concerns, the majority of patients with MFS are restricted from certain physical activities, most commonly isometric exercise and contact sports. Published guidelines also suggest restriction from highly dynamic competitive sports. While clinicians may mean to restrict patients only from competitive sports, often children and families interpret this caution as applying to almost all exercise, resulting in a large number of patients with Marfan syndrome being sedentary. This lack of exercise and deconditioning likely have detrimental effects in increasing weakness and joint pain and decreasing endurance. Depressive symptoms are also not uncommon in Marfan syndrome, and may be triggered or exacerbated by guidance to acutely cease participation in sports at the time of diagnosis.

To date, as far as the investigators are aware, there are no published controlled studies on the effects of dynamic exercise on human subjects. In 2017, Mas-Stachurska et al published a study suggesting that a moderate level of dynamic exercise mitigated progressive degradation of the cardiac structures typically seen in Marfan Syndrome in a rodent sample. This study suggests the possibility that the fears surrounding moderate exercise in humans may be unwarranted. In addition, this study suggests that moderate exercise may actually protect the aorta and myocardium, in addition to the numerous other physical and emotional benefits that have been shown to result from consistent exercise. The overall goal is to evaluate the effects of a moderate dynamic exercise program on measures of cardiovascular, muscular, and mental health in adolescents and young adults with Marfan syndrome. The investigators plan to perform a randomized pilot study to calculate effect estimates to perform a larger multi-center study. The objective is to 1) randomize 20 patients with Marfan syndrome age 12-21 years to current status (controls) versus a moderate dynamic exercise intervention, then 2) allow the control group patients to undergo the exercise intervention. The investigators will then compare outcomes between both the intervention and control groups, and between the baseline and post-intervention states. Specific outcome measures will include cardiovascular assessment: maximal oxygen uptake (max VO2), segmental and central aortic stiffness, ventricular mass and volume, and endothelial function, muscular/physical assessment: manual muscle testing (MMT), functional balance, and pain assessment, and quality of life/mental health assessment: health-related quality of life, depression and anxiety screening scales. The hypothesis is that the intervention of a moderate exercise program introduced by a licensed physical therapist will result in improvement in cardiovascular status, muscular health, and mental health without detrimental effects on the aortic wall.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

盲法说明

The primary investigator and the co-PI (physical therapist) will know whether testing is at baseline or follow-up, but will not know the cardiovascular outcome measures. The cardiovascular outcomes assessor will be fully blinded.

入排标准

年龄范围
12 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Must be between the ages of 12-21
  • Diagnosis of Marfan Syndrome
  • Must not have other conditions that limit the patients ability to perform exercise

排除标准

  • Patients who have undergone aortic surgery
  • Patients with major congenital heart disease

结局指标

主要结局

Maximum VO2

时间窗: 4 months

Maximum VO2 in ml/kg/minute will be collected via Exercise Stress Test. Range 30-85, higher is better.

次要结局

  • Maximum aortic root dimension(4 months)
  • BMI(4 months)
  • Aortic Root β-Stiffness index(4 months)
  • Left ventricular strain by cardiac MRI(4 months)
  • Aortic root strain(4 months)
  • Aortic Root Distensibility(4 months)
  • Reactive hyperemia index(4 months)
  • 6M Timed Hop Test(4 months)
  • Pediatric Quality of Life Scale (PedsQL) scale scores(4 months)
  • Weight(4 months)
  • Aortic root z-score(4 months)
  • Pulse wave velocity derived from applanation tonometry(4 months)
  • Visual analog assessment of pain(4 months)
  • Quality of Life Scale (QOLS) (ages 19-21 y)(4 months)
  • Mean Diastolic blood pressure(4 months)
  • Right ventricular strain by cardiac MRI(4 months)
  • Mean systolic blood pressure(4 months)
  • Mean pulse pressure(4 months)
  • Aortic pulse wave velocity from MRI(4 months)
  • Augmentation index(4 months)
  • Single limb squat test score(4 months)
  • Scale for Child Anxiety Related Emotional Disorders (SCARED) (ages 12-18 y)(4 months)
  • Manual muscle testing score(4 months)
  • Single Leg Stance Test(4 months)
  • Star Excursion Balance Test(4 months)
  • Depression, Anxiety, & Stress Scale (DASS) (ages 19-21 y)(4 months)
  • Children's Depression Inventory (CDI) 2 (ages 12-18 y)(4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shaine Morris

Associate Professor, Pediatrics-Cardiology

Baylor College of Medicine

研究点 (2)

Loading locations...

相似试验

Marfan Syndrome Moderate Exercise Pilot | 临床试验